Table 3.
The final diagnosis according to LI-RADS classes.
| LI-RADS Classes (n = 191) | ||
|---|---|---|
| The Final Diagnosis | n (%) | LI-RADS Classes |
| Malignant | 159 (83.2%) | |
| HCC | 141 (73.83%) | LR-5 = 81 (57.4%) LR-4 = 37 (26.2%) LR-3 = 3 (2.12%) LR-M = 13 (9.21%) LR-NC = 7 (4.96%) |
| ICC | 4 (2.09%) |
LR-M = 3 LR-5 = 1 |
| mixed tumor (HCC/ICC) | 3 (1.57%) |
LR-M = 3 |
| metastases | 10 (5.23%) | LR-M = 10 |
| malignant transformation of hepatocellular adenomas | 1 (0.52%) |
LR-5 = 1 |
| Benign | 32 (16.7%) | |
| regenerative/dysplastic nodule | 19 (9.9%) |
LR-1 = 3 LR-2 = 6 LR-3 = 5 LR-4 = 2 LR-NC = 3 |
| FNH | 1 (0.5%) |
LR-2 = 1 |
| hemangioma | 6 (3.1%) |
LR-1 = 5 LR-5 = 1 |
| complex cyst | 6 (3.1%) | LR-1 = 6 |
HCC—hepatocellular carcinoma; ICC—intrahepatic cholangiocellular carcinoma; FNH—focal nodular hyperplasia.